Cellworks Study Predicted Non-Response to Azacitidine in MDS Patients with 100% Accuracy using AI-Driven Biosimulation
02 déc. 2018 21h00 HE
|
Cellworks Group, Inc.
SAN DIEGO, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that its AI-driven...
UPDATE -- Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
19 nov. 2018 10h41 HE
|
Cellworks Group, Inc.
SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that...
Cellworks to Present 10 Abstracts at 2019 American Society of Hematology Annual Meeting
19 nov. 2018 10h00 HE
|
Cellworks Group, Inc.
SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that...